PortView
Liminatus Pharma (LIMNW) Stock Analysis
NASDAQHealthcareBiotechnology
What Liminatus Pharma does
Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.
Key metrics
ETFs linked to LIMNW
Broad-market and Healthcare sector ETFs an investor holding Liminatus Pharma is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how LIMNW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze LIMNW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Liminatus Pharma?
- Liminatus Pharma trades under the ticker LIMNW on NASDAQ.
- Which exchange is LIMNW listed on?
- LIMNW is listed on NASDAQ.
- What sector does Liminatus Pharma operate in?
- Liminatus Pharma is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze LIMNW in a portfolio?
- PortView shows LIMNW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.